Item 5. Market for Registrant’s Common Equity
ITEM 5.
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market Information
Our common stock eligible for quotation on the
Pink Market OTC Markets Group Inc. under the symbol “CDIX.” The following table sets forth, for the periods indicated, the
high and low closing prices of our common stock. These prices reflect inter-dealer prices, without retain mark-up or commission, and may
not represent actual transactions.
Closing Prices
High
Low
Fiscal Year Ended December 31, 2022
1 st Quarter
$
375.00
$
7.50
2 nd Quarter
$
15.00
$
15.00
3 rd Quarter
$
375.00
$
15.00
4 th Quarter
$
217.50
$
22.50
Fiscal Year Ended December 31, 2023
1 st Quarter
$
412.50
$
15.00
2 nd Quarter
$
75.00
$
7.50
3 rd Quarter
$
60.00
$
7.50
4 th Quarter
$
105.00
$
7.50
Number of Holders of Our Common Shares
As of March 22, 2024, there were approximately
881 stockholders of record of our common stock. In computing the number of holders of record of our common stock, each broker-dealer and
clearing corporation holding shares on behalf of its customers is counted as a single stockholder.
Securities Authorized for Issuance Under Equity
Compensation Plans
As of December 31, 2023, we did not have in effect
any compensation plans under which our equity securities were authorized for issuance, and we did not have any outstanding share options.
Dividend Policy
We have never declared or paid cash dividends
on our capital stock. We currently intend to retain all available funds and any future earnings for use in the operation of our business
and do not anticipate paying any cash dividends in the near future. Any decision to declare and pay dividends in the future will be made
at the discretion of our board of directors and will depend on, among other things, our results of operations, financial condition, cash
requirements, contractual restrictions, and other factors that our board of directors may deem relevant. In addition, our ability to pay
dividends may be limited by covenants of any existing and future outstanding indebtedness we or our subsidiaries incur.
36
Recent Sales of Unregistered Securities
Except as set forth below, we have not sold any
equity securities during the 2023 fiscal year that were not previously disclosed in a quarterly report on Form 10-Q or a current report
on Form 8-K that was filed during the 2023 fiscal year.
Purchases of Equity Securities
No repurchases of our common stock were made
during the fourth quarter of 2023.
ITEM 6.
[RESERVED]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.